Xellera Therapeutics operates Hong Kong’s first multi-product cGMP facility, featuring advanced Grade A/B cleanrooms and integrated QC, R&D, and process development labs. Purpose-built for scalable and flexible production, the facility supports clinical to commercial manufacturing aligned with US FDA, EMA, PIC/S, and HK DoH regulations. https://www.xelleratherapeutics.com/facilities/